Multisample Tissue Grinder Market Overview
The Multisample Tissue Grinder Market is expanding as biotechnology, pharmaceutical, and life-science research activities increase the demand for efficient and precise tissue sample preparation. Growing investments in biomedical research, increasing genomic studies, laboratory automation, and the need for consistent sample processing are supporting market growth.
According to the WiseGuyReports market report published in April 2026, the global Multisample Tissue Grinder Market was valued at USD 700 Million in 2024 and is projected to remain at USD 700 Million in 2025 before reaching USD 1.2 Billion by 2035, registering a CAGR of 5.6% during 2025–2035. North America is expected to dominate the market, with the regional market valued at USD 280 Million in 2024 and projected to reach USD 460 Million by 2035. Biotechnology was the leading application segment, valued at USD 250 Million in 2024 and projected to reach USD 430 Million by 2035.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/sample-request?id=623124
Key players driving innovation and competitiveness in the Multisample Tissue Grinder Market include:
Benchmark Scientific
Streck
Fisher Scientific
Eppendorf AG
Sartorius AG
Hettich Lab Technology
VWR International
SAVANT
Thermo Fisher Scientific
Heidolph Instruments
Biospec Products
Kimble Chase
Omni International
Corning Inc
MilliporeSigma
The market is being shaped by increasing research activities in biotechnology, pharmaceuticals, molecular biology, and clinical research. Laboratories are increasingly adopting automated and motorized tissue grinders to improve sample-processing efficiency, consistency, and throughput. The growing focus on reducing contamination and achieving reproducible sample preparation is also encouraging the adoption of advanced tissue-processing equipment.
The Multisample Tissue Grinder Market can be segmented by Application into Biotechnology, Pharmaceuticals, Research Laboratories, and Academic Institutions. By Type, it includes Handheld Tissue Grinders, Motorized Tissue Grinders, and Homogenizers. By Material, it covers Metal, Plastic, and Glass. By End Use, it includes Clinical Research, Diagnostic Laboratories, and Food and Beverage Testing. Regionally, the market covers North America, Europe, South America, Asia Pacific, and the Middle East and Africa.
The growing need for accurate and efficient tissue processing is creating opportunities for laboratory-equipment manufacturers, biotechnology companies, pharmaceutical companies, research institutions, and diagnostic laboratories. Automated grinding systems, high-throughput equipment, multifunctional grinders, sustainable materials, and advanced laboratory automation can support market differentiation and future growth.
Recent Developments and Market Trends:
Increasing biotechnology and pharmaceutical research activities are driving demand for efficient tissue-processing and sample-preparation equipment.
Automated and motorized tissue grinders are gaining traction because they provide greater consistency, efficiency, and throughput compared with manual alternatives.
Laboratory automation is becoming increasingly important as research organizations seek to reduce processing time and improve reproducibility.
Technological advancements are supporting the development of high-throughput multisample tissue grinders for laboratories handling larger sample volumes.
Sustainable and eco-friendly materials are gaining attention as laboratories increasingly focus on reducing environmental impact.
The growing demand for precise sample preparation in genomic, molecular biology, and biomedical research is creating additional opportunities for advanced tissue grinders.
Emerging markets in Asia Pacific are supporting market expansion as healthcare expenditure, biotechnology research, and laboratory infrastructure continue to increase.
Key developments include Sartorius AG’s acquisition of Sphere Biotechnologies’ tissue processing division in May 2025, Thermo Fisher Scientific’s collaboration with Eppendorf AG in March 2025 to develop automated tissue-grinding workflows, and Heidolph Instruments’ launch of the HeiBead 360 high-throughput multisample tissue grinder in February 2025.
North America is expected to retain its leading position in the Multisample Tissue Grinder Market due to established healthcare infrastructure, strong biotechnology research, and high investment in laboratory technologies. Europe is expected to maintain steady growth, supported by investments in life sciences, healthcare, and laboratory automation. Asia Pacific is positioned for significant growth as research infrastructure, healthcare expenditure, and biotechnology activities expand. South America and the Middle East and Africa are expected to witness gradual growth as healthcare and research capabilities develop.
Reasons to Buy the Report:
Provides comprehensive insights into the Multisample Tissue Grinder Market dynamics, trends, opportunities, and growth potential.
Helps identify opportunities across biotechnology, pharmaceuticals, research laboratories, and academic institutions.
Offers detailed segmentation analysis across application, type, material, end use, and geographic markets.
Includes competitive intelligence covering leading laboratory-equipment, biotechnology, and life-science companies.
Supports informed decisions using market forecasts, biotechnology research trends, laboratory automation, genomic studies, healthcare investment, and regional opportunities.
Future Outlook:
The future of the Multisample Tissue Grinder Market will be shaped by increasing biotechnology and pharmaceutical research, growing demand for precise sample preparation, laboratory automation, genomic studies, and technological advancements in tissue-processing equipment. Biotechnology should remain a leading application segment, with the segment projected to increase from USD 250 Million in 2024 to USD 430 Million by 2035. North America is expected to retain its leadership position, with the regional market projected to grow from USD 280 Million in 2024 to USD 460 Million by 2035. Asia Pacific is positioned for strong growth as research infrastructure and biotechnology investment increase. The global Multisample Tissue Grinder Market is projected to reach USD 1.2 Billion by 2035 at a CAGR of 5.6%.
➤➤Explore Our Latest Related Reports:
